Transcatheter Mitral valve replacement Market is estimated to be US$ 14.5 billion by 2030 with a CAGR of 31.4% during the forecast period

 



Transcatheter Mitral valve replacement market accounted for US$ 0.92 billion in 2020 and is estimated to be US$ 14.5 billion by 2030 and is anticipated to register a CAGR of 31.4%.Mitral valve dysfunction happens when the valve does not function properly, causing irregular blood flow. This irregular blood flow causes two diseases: mitral valve prolapse and regurgitation. The mitral valve is located between the left atrium and the left ventricle. For patients who are unable or unwilling to undergo surgery, transcatheter mitral valve replacement (TMVR) has emerged as an alternative treatment option. Transcatheter mitral valve replacement provides excellent hemodynamic efficiency with a low rate of residual mitral regurgitation and low transvalvular gradients.

The report " Transcatheter Mitral valve Replacement Market, By Product (mechanical valve and Bioprosthetic tissue valve), By Diagnostic test (lateral flow assay, PCR assay, latex Agglutination tests),By End-user (hospital, clinics and others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

·         In March 2019, the U.S. Food and Drug Administration extended and approved MitraClip's recommendations for treating functional (secondary) mitral regurgitation.

·         In Aug 2020, CardioMech AS, a medical device company based in Minneapolis, is working on a transfemoral, transseptally delivered mitral valve repair technology

Analyst View:

Because of increasing incidences of mitral valve diseases, new pipeline devices, and an ageing population with heart disorders, demand for Transcatheter Mitral Valve Implantation (repair and replacement) is projected to grow at a healthy pace during the forecast era. Due to an increase in the geriatric population and an increase in mitral valve disorders, Technological advancements and the introduction of new mitral valves are two other factors that lead to market development. In terms of safety and efficacy, these interventions are proving to be beneficial for patients who are at risk of developing mitral valve disease.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

The Transcatheter Mitral valve replacement market accounted for US$ 0.92  billion in 2020 and is estimated to be US$ 14.5 billion by 2030 and is anticipated to register a CAGR of 31.4%. The Transcatheter Mitral valve replacement Market is segmented based on the product, application, end-use and region.

·         By product, the Transcatheter mitral valve replacement Market is segmented into mechanical valves and Bioprosthetic tissue valves.

·         By Application, the Transcatheter mitral valve replacement Market is segmented into mitral valve stenosis, mitral valve prolapse and mitral valve Regurgitation.

·         By End-use, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers and others.

·         By region, the Transcatheter mitral valve replacement Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. 

Competitive Landscape:

The key players operating in the Transcatheter Mitral valve replacement market includes Abbott Laboratories, Biotronik Pvt Ltd, Colibri Heart Valve, LLC, Edward Lifesciences, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., NeoChord, Venus Medtech, Transcatheter Technologies GmbH, MValve Technologies and Mardil Medical.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more